Remove Biosimilars Remove Documentation Remove Process Improvement
article thumbnail

NHC Submits Comments on CMS Draft Guidance for IPAY 2028

Putting Patients First Blog

CMS should draw on lessons from previous transitions, including biosimilar coverage rollouts and site-of-care policy shifts, to avoid known implementation pitfalls. These materials should be made available in multiple formats and languages and cover billing practices, coinsurance changes, and patient rights in plain language. 7 Gabriella M.